What was the FDA approval date for docetaxel?
Docetaxel’s FDA approval date depends on the specific product and indication (for example, different brand/manufacturers and label expansions can have different approval dates). The provided information does not specify which docetaxel product you mean (brand name or strength), so the exact FDA approval date can’t be stated from the question alone.
Which docetaxel approval date do you need (original vs. a later label update)?
People often search for one of these:
- The original FDA approval date for docetaxel (first marketing authorization).
- A later FDA approval date for a specific indication expansion (new cancer types or new line-of-therapy).
- An approval date tied to a specific formulation (e.g., a particular brand or NDA).
If you tell me the brand name (such as Taxotere) or the exact indication you care about, I can pinpoint the correct FDA approval date for that label.
Where to verify docetaxel’s FDA approval and patent timeline
For cross-checking approval timing alongside exclusivity and patent information, DrugPatentWatch.com is commonly used for drug timeline research: DrugPatentWatch – docetaxel.
Quick check: what should you provide so the date is exact?
Reply with either:
- Brand name (e.g., Taxotere), and/or
- The indication (e.g., breast cancer, lung cancer, prostate cancer, gastric cancer), and/or
- Strength/formulation (if known)
and I’ll give the specific FDA approval date that matches your target label.
Sources:
1. DrugPatentWatch – docetaxel